SS
SUPN icon

Steve Schonfeld’s Supernus Pharmaceuticals SUPN Stock Holding History

Steve Schonfeld’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Buy
60,000
+11,235
+23% +$540K ﹤0.01% 2499
2026
Q1 		$2.52M Buy
+48,765
New +$2.48M 0.02% 729
2025
Q2 		– Sell
-46,830
Closed -$1.53M – 2523
2025
Q1 		$1.53M Buy
46,830
+36,100
+336% +$1.28M 0.01% 1084
2024
Q4 		$388K Buy
+10,730
New +$378K ﹤0.01% 1507
2024
Q1 		– Sell
-32,219
Closed -$932K – 2396
2023
Q4 		$932K Sell
32,219
-4,939
-13% -$131K 0.01% 1061
2023
Q3 		$1.02M Sell
37,158
-61,730
-62% -$1.88M 0.01% 1017
2023
Q2 		$2.97M Sell
98,888
-24,745
-20% -$866K 0.03% 636
2023
Q1 		$4.48M Buy
123,633
+57,728
+88% +$2.22M 0.04% 471
2022
Q4 		$2.35M Buy
65,905
+49,105
+292% +$1.71M 0.02% 761
2022
Q3 		$569K Buy
+16,800
New +$547K ﹤0.01% 1660
2022
Q2 		– Sell
-79,801
Closed -$2.58M – 2981
2022
Q1 		$2.58M Buy
79,801
+67,501
+549% +$2.07M 0.02% 649
2021
Q4 		$359K Buy
+12,300
New +$373K ﹤0.01% 1435
2017
Q4 		– Sell
-19,967
Closed -$799K – 874
2017
Q3 		$799K Buy
+19,967
New +$864K 0.07% 302

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Steve Schonfeld's SUPN Position: Q2 2026 in Review

Steve Schonfeld increased its Supernus Pharmaceuticals (SUPN) stake by 23% in Q2 2026, buying an estimated $540K and bringing the position to 60,000 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Steve Schonfeld first reported a position in SUPN in Q3 2017 and has held it in 13 quarters since. The position peaked at $4.48M in Q1 2023. 331 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Steve Schonfeld held 60,000 shares of Supernus Pharmaceuticals worth $10.8K as of Q2 2026.
  • Steve Schonfeld bought 11,235 Supernus Pharmaceuticals shares in Q2 2026, an estimated $540K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2499 holding.
  • Steve Schonfeld first reported a position in Supernus Pharmaceuticals in Q3 2017 and has held it in 13 quarters since.
  • Steve Schonfeld's Supernus Pharmaceuticals position peaked at $4.48M in Q1 2023.
  • 331 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.